Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
STS Biopolymers was a medical technology company specializing in the development and manufacture of biocompatible coatings for medical devices. The company's proprietary technologies, such as the "Slippery-When-Wet" lubricious coatings and antimicrobial surface treatments, were designed to improve the performance and safety of catheters, guide wires, and other interventional tools. By providing advanced surface modification solutions, STS Biopolymers enabled medical device manufacturers to enhance device trackability and reduce patient complications. Their portfolio also included drug-delivery coatings capable of controlled release of therapeutic agents from device surfaces. The company was acquired by Angiotech Pharmaceuticals in 2003 to strengthen their position in the interventional medicine and biomaterials markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on STS Biopolymers.